Dr Martine Keenan Co-Authors Book Chapter

Challenging the status quo is a necessity in drug discovery to keep research moving forwards. Our Head of Drug Discovery, Dr Martine Keenan, co-authored a book chapter in the recently published volume Neglected Tropical Diseases: Drug Discovery and Development with Dr Eric Chatelain from the Drugs for Neglected Diseases initiative. Martine and Eric discuss the challenges … Read more

Epichem Steroids: A New Adventure in High Purity Polycyclic Chemistry

Our new steroid category is growing and consists of both fully characterised reference standards made under our ISO 17034 and ISO 17025 accreditation such as EPL-AA211 (Δ9,11-promestriene) and our high purity fine chemical steroids such as EPL-DV4 (17α-methyltestosterone).   We are also proud to announce that Epichem has made its first sale from the new … Read more

Sweet Sixteen!

This week Epichem celebrated its 16th Birthday! Conceived from a desire to solve difficult synthetic chemistry problems and to provide jobs for home-grown PhD organic chemists, Epichem was established from humble beginnings in 2003. Today we stand proud to provide a suite of products and services to key customers and stakeholders around the world, across … Read more

Introducing our New CEO, Colin La Galia!

Introducing Colin La Galia! We’re pleased to announce that Colin has joined Epichem as its new Chief Executive Officer. Colin brings 25 years of domestic and international pharmaceutical, diagnostics and healthcare senior executive experience to the role of CEO at Epichem and Director on the Epichem Board. Formerly the Regional Business Director and Commercial Head … Read more